![]() | Up a level |
Amraee, A. and Evazi, M.R. and Shakeri, M. and Roozbeh, N. and Ghazanfarpour, M. and Ghorbani, M. and Ansari, J. and Darvish, L. (2019) Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study. Clinical and Translational Oncology.